Key Points
Drug major Cipla is eyeing acquisitions and inorganic partnerships in the US market while consolidating its presence across segments in the domestic market..
The Mumbai-based company is also looking to improve the top line in Europe and margin expansion in South Africa...
"Product launches through delisting strategy and as well as inorganic partnerships and acquisitions will remain one of our key priorities for the US market," Cipla Global Chief Financial Officer Ashish Adukia said in an analyst call...
In the South African market, Cipla would build on its performance aided by growth in private and select tender business with greater emphasis on margin expansion, Adukia stated...
Cipla MD and CEO Umang Vohra said that "derisking our top launches remains our top priority" as the company focuses on resolving regulatory issues at various manufacturing plants...
You might be interested in
Cipla Q2 Results: Profit jumps 43% YoY to Rs 1,131 crore, revenue rises 15%
27, Oct, 23The bottomline was higher than the Rs 1,006 crore which was expected by analysts in an ET Now poll. Cipla's consolidated margin came in at 26% during the quarter.
Cipla Q3 Results: Profit jumps 32% YoY to Rs 1,056 crore, revenue rises 14%
22, Jan, 24Cipla's Q3 revenue for the quarter grew 13.7% YoY to Rs 6,604 crore, compared to Rs 5,810 crore in the same quarter last year. However, the drugmaker saw a marginal decline from the previous quarter's revenue of Rs 6,678 crore. Meanwhile, its EBITDA surged 24.2% YoY to Rs 1,748 crore in the December quarter of FY24.
Stocks to Watch: Dr Reddy's, Federal Bank, Titan, Adani Wilmar, JSW Steel
08, Jan, 24FPI net inflows into Indian equities and debt in 2023-24 have reached a nine-year high. At ₹2.68 trillion, this is just ₹9,625 crore away from 2014-15’s record net inflows of ₹2.77 trillion.
Marico Q2 Net profit up 17% to Rs 353 crore
30, Oct, 23India Business News: Marico, a parachute maker, reported a 17% increase in net profit in the second quarter. Revenue from operations, however, was down 1%. The company not
Tata Consumer Q2 Results: Profit rises 3% YoY to Rs 338 crore; revenue up 11%
31, Oct, 23Revenue from operations during the reporting second quarter jumped 11% year-on-year (YoY) to Rs 3,734 crore. The same was at Rs 3,363 crore in the last year quarter. The revenue growth was driven by an underlying growth of 11% in the India business, 8% in the International business, and 3% in the non-branded business.
Dr Reddy's Q1 Results: PAT up 18% YoY at Rs 1,405 crore, tops estimate
26, Jul, 23The EBITDA or earnings before interest, taxes, depreciation, and amortisation, for the quarter increased 20% on year to Rs 2,137 crore. However, margins compressed a sharp 240 basis points to 31.7%.
Nestle India Q1 Results: Profit jumps 25% YoY to Rs 737 crore, beats estimates
25, Apr, 23Nestle India Chairman and Managing Director Suresh Narayanan said it is the highest growth for the company in a quarter in the last 10 years after excluding the exceptional quarter in 2016 which was off a low base in 2015. The Maggi maker said the company is witnessing early signs of softening of commodities such as edible oils, wheat and packaging materials.
Marico Q4 net up 20% to Rs 302 crore, aided by other income
05, May, 23India Business News: MUMBAI: Marico reported a 20% growth in its reported profit after tax (PAT) at Rs 302 crore in the fourth quarter ended March 31, 2023, as compared to.
PB Fintech Q4 Results: Loss shrinks to Rs 9 crore; Policybazaar parent co breaks even at operating level
22, May, 23Revenue from operations was up 61% YoY at Rs 869 crore, while credit disbursals saw a 53% YoY jump showcasing the company's potential growth in the credit market. The firm's core business adjusted EBITDA reached Rs64 crore during March, and its consolidated adjusted EBITDA stood at Rs 28 crore.
Cipla Q1 Results: Cons PAT soars 45% YoY to Rs 996 crore, beats estimates
26, Jul, 23Consolidated operating profit, calculated as earnings before interest, taxes, depreciation, and amortization (EBITDA), grew by 31% on year to Rs 1,494.02 crore. Operating margin expanded a sharp 234 basis points to 23.6%.